2020 has proven to be a remarkable year, to be sure. The global pandemic has been an ever-present specter that has colored just about every major storyline for the year, whether you’re talking about politics, economics, social trends, or just about anything else. As it relates to investments, the market’s plunge from late February to […]
Read MoreThe last week has been impressive to watch. With elections in the U.S. translating to a change in residency at the White House (Trump out, Biden in), while the House and Senate remain split between parties, the market seems to be interpreting the result in a positive light. Some of that, presumably reflects a hope […]
Read MoreMarket commentary seems to have shifted a bit to focus on the political theater – both whether a second set of stimulus programs will be reached before the upcoming election, or speculation about the election itself. The unrelenting focus on COVID-19 vaccines up to now seems to have faded a bit, even though the pandemic […]
Read MoreBuy Price: $123.00 or better Sell Price: TradersPro Sell Signal Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company’s lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that […]
Read More